T1	Diagnosis 57 71	Focal-epilepsy
A1	CUIPhrase T1 focal-epilepsy
A2	Negation T1 Affirmed
A3	DiagCategory T1 Epilepsy
A4	Certainty T1 5
A5	CUI T1 C0014547
T15	EpilepsyCause 85 103	Tuberous-sclerosis
A15	Certainty T15 5
A16	Negation T15 Affirmed
A17	CUIPhrase T15 Tuberous-sclerosis
A18	CUI T15 C0041341
T22	PatientHistory 356 374	tuberous-sclerosis
A23	Certainty T22 5
A24	Negation T22 Affirmed
A25	CUIPhrase T22 tuberous-sclerosis
A26	CUI T22 C0041341
T31	PatientHistory 1453 1471	tuberous-sclerosis
A35	Certainty T31 5
A36	Negation T31 Affirmed
A37	CUIPhrase T31 tuberous-sclerosis
A38	CUI T31 C0041341
T2	PatientHistory 1454 1472	tuberous-sclerosis
A6	Negation T2 Affirmed
A7	Certainty T2 5
A8	CUI T2 C0041341
A9	CUIPhrase T2 Tuberous-sclerosis
T3	Investigations 494 502	MRI-scan
A10	CUI T3 C1319851
A11	MRI_Performed T3 Yes
A12	CUIPhrase T3 mri-abnormal
A13	MRI_Results T3 Abnormal
T4	PatientHistory 633 641	seizures
A14	CUIPhrase T4 C0036572
A1510	Certainty T4 5
A1610	CUI T4 C0036572
A1710	Negation T4 Affirmed
T5	Prescription 143 167	Eslicarbazepine-800mg-od
A1810	CUIPhrase T5 eslicarbazepine
A19	DrugDose T5 800
A201	DrugName T5 eslicarbazepine
A211	CUI T5 C2725260
A221	Frequency T5 1
A232	DoseUnit T5 mg
T6	WhenDiagnosed 385 392	epileps
A242	Age T6 6
A252	CUI T6 C0014544
A262	Certainty T6 5
A27	AgeUnit T6 Year
A28	Negation T6 Affirmed
A29	CUIPhrase T6 epilepsy
T7	Diagnosis 643 670	Focal-frontal-lobe-seizures
A30	CUIPhrase T7 frontal-lobe-seizures
A31	DiagCategory T7 MultipleSeizures
A32	Certainty T7 5
A33	Negation T7 Affirmed
A34	CUI T7 C0085541
T11	Diagnosis 385 394	epilepsy-
A45	CUIPhrase T11 epilepsy
A46	Negation T11 Affirmed
A47	CUI T11 C0014544
A48	DiagCategory T11 Epilepsy
A49	Certainty T11 5
T12	Diagnosis 643 648	Focal
A50	CUI T12 C0751495
A51	DiagCategory T12 MultipleSeizures
A52	Certainty T12 5
A53	CUIPhrase T12 focal-seizures
A54	Negation T12 Affirmed
T13	Prescription 105 142	Medication:-Sodium-valproate-500mg-bd
A55	DrugName T13 sodium-valproate
A56	CUIPhrase T13 sodium-valproate
A57	CUI T13 C0037567
A58	Frequency T13 2
A59	DrugDose T13 500
A60	DoseUnit T13 mg
T14	Diagnosis 804 842	focal-to-bilateral-convulsive-seizures
A61	Certainty T14 5
A62	CUIPhrase T14 focal-to-bilateral-convulsive-seizures
A63	DiagCategory T14 MultipleSeizures
A64	CUI T14 C0877017
A65	Negation T14 Affirmed
T16	Diagnosis 1425 1434	epilepsy-
A66	CUI T16 C0014544
A67	Certainty T16 5
A68	DiagCategory T16 Epilepsy
A69	CUIPhrase T16 epilepsy
A70	Negation T16 Affirmed
T17	SeizureFrequency 643 669	Focal-frontal-lobe-seizure
A75	TimePeriod T17 Month
A76	CUIPhrase T17 frontal-lobe-seizure
A77	UpperNumberOfSeizures T17 5
A78	NumberOfTimePeriods T17 1
A79	LowerNumberOfSeizures T17 4
A80	CUI T17 C0085541
T18	SeizureFrequency 804 841	focal-to-bilateral-convulsive-seizure
A81	NumberOfSeizures T18 0
A82	TimePeriod T18 Year
A83	NumberOfTimePeriods T18 2
A84	CUI T18 C0877017
A85	CUIPhrase T18 focal-to-bilateral-convulsive-seizure
T19	EpilepsyCause 1454 1472	tuberous-sclerosis
A202	Certainty T19 5
A212	Negation T19 Affirmed
A222	CUIPhrase T19 Tuberous-sclerosis
A232	CUI T19 C0041341
